Assessing Tolerability of Avonex Intramuscular Injections

Completed · Not applicable

Conditions studied: Multiple Sclerosis

In brief

The purpose of this study is to evaluate patients' views when injecting Avonex intramuscularly.

Key facts

Study ID

NCT01641120

Run by

Trinity Health Of New England

People needed

20

Starts

2012-05-01

Expected to finish

2014-02-01

Last updated by the study team

2016-02-01

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Between 18 - 65 years of age;
• Confirmed diagnosis of Relapsing Remitting Multiple Sclerosis;
• Currently being treated with Avonex® for at least 90 days;
• Using 25 gauge needles for injection of Avonex® for at least 90 days;
• Willing and able to complete study questionnaires; and
• Provided informed consent to participate in this study

You may not qualify if…

• Diagnosis of Progressive Multiple Sclerosis;
• History of recent illness or infection;
• History of allergic reaction to Avonex®;
• Any prior usage of a 30 gauge needle for administration of Avonex®;
• Concurrent treatment with other immunomodulating therapies;
• Pregnant or planning on becoming pregnant;
• Nursing mothers; and
• Unable to complete the requirements of the study

Where it is running

• The Mandell Center for Multiple Sclerosis — Hartford, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.